Volumetric cortical loss in sporadic and familial amyotrophic lateral sclerosis.
Patients homozygous for the D90A mutation of the SOD1 gene (homD90A) demonstrate markedly slower progression of disease than those patients with sporadic ALS (SALS). PET studies have demonstrated a different cortical vulnerability in the two groups, reflected also in neurophysiological studies showi...
Asıl Yazarlar: | Turner, M, Hammers, A, Allsop, J, Al-Chalabi, A, Shaw, C, Brooks, D, Leigh, P, Andersen, P |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2007
|
Benzer Materyaller
-
Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-flumazenil PET.
Yazar:: Turner, M, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
Cortical localisation of neuropsychological impairment in amyotrophic lateral sclerosis (ALS): An [C-11] Flumazenil PET study
Yazar:: Wicks, P, ve diğerleri
Baskı/Yayın Bilgisi: (2005) -
Neuronal loss associated with cognitive performance in amyotrophic lateral sclerosis: an (11C)-flumazenil PET study.
Yazar:: Wicks, P, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis.
Yazar:: Turner, M, ve diğerleri
Baskı/Yayın Bilgisi: (2002) -
Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.
Yazar:: Turner, M, ve diğerleri
Baskı/Yayın Bilgisi: (2005)